BioLife Solutions, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- BioLife Solutions, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-06-30 was 2.00K shares, a 80.00% decline year-over-year.
- BioLife Solutions, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-03-31 was 100.00K shares.
- BioLife Solutions, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- BioLife Solutions, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-06-30 was 10.00K shares, a 72.41% decline year-over-year.
- BioLife Solutions, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 161.65K shares.
- BioLife Solutions, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2013 was -25.42K shares.
- BioLife Solutions, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2012 was 0.00 shares.
- BioLife Solutions, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2011 was 0.00 shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2026-06-30 | 2.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | |
| 2026-03-31 | 100.00K shares 10-Q · filed 2026-05-07 | |
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | |
| 2025-06-30 | 10.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | |
| 2025-03-31 | 0.00 shares 10-Q · filed 2026-05-07 | |
| 2024-09-30 | 22.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | |
| 2024-06-30 | 36.25K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | |
| 2024-03-31 | 0.00 shares 10-Q · filed 2024-05-10 | |
| 2022-12-31 | 161.65K shares 10-K · filed 2024-02-29 | |
| 2018-03-31 | 62.44K shares 10-Q · filed 2018-05-11 | |
| 2013-12-31 | 330.44K shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-12 | -25.42K shares 10-K · filed 2014-02-12 |
| 2013-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | |
| 2013-06-30 | 1.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-12 | |
| 2013-03-31 | -355.86K shares 10-Q · filed 2013-05-14 | |
| 2012-12-31 | 0.00 shares 10-K · filed 2014-02-12 | |
| 2011-12-31 | 0.00 shares 10-K · filed 2013-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |